Cite
HARVARD Citation
Daniele, G. et al. (n.d.). H01*A multicenter, randomised, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients (pts). The STAD-1 trial. Annals of oncology. p. vi. [Online].